Although initial evaluations of the potential of BRD9‐based targeted therapy have been explored in their preclinical research for a small number of cancer types (Table S5), more comprehensive study of the diagnostic and prognostic potential, as well as the detailed biological mechanism of BRD9 remain unreported. Here, BRD9 is linked to cancer.